Arformoterol Tartrate Inhalation Solution 76204-0026-02
- Manufacturer
- Ritedose Pharmaceuticals, Llc
- Dosage Form
- Solution
- Route
- Respiratory (inhalation)
- Product Type
- Human Prescription Drug
- Marketing Start
- February 27, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA214736
Need to source Arformoterol Tartrate Inhalation Solution? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Arformoterol Tartrate | 15 ug/2mL |
Drug Class
Adrenergic beta2-Agonists [MoA]beta2-Adrenergic Agonist [EPC]
Selected Package
76204-0026-02Selected60 POUCH in 1 CARTON (76204-026-02) / 1 AMPULE in 1 POUCH / 2 mL in 1 AMPULE
Other packages for this product(2)
30 POUCH in 1 CARTON (76204-026-01) / 1 AMPULE in 1 POUCH / 2 mL in 1 AMPULE
12 POUCH in 1 CARTON (76204-026-55) / 5 AMPULE in 1 POUCH / 2 mL in 1 AMPULE